Full Text View
Tabular View
No Study Results Posted
Related Studies
Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)
This study is currently recruiting participants.
Verified by Nagoya University, September 2007
First Received: December 6, 2006   Last Updated: September 19, 2007   History of Changes
Sponsored by: Nagoya University
Information provided by: Nagoya University
ClinicalTrials.gov Identifier: NCT00408824
  Purpose

The metabolic syndrome is a highly prevalent disorder, which causes atherosclerotic cardiovascular disease and is closely associated with insulin resistance. The alteration of the secretion of adipocytokines from accumulated visceral adipose tissue in the obese induces insulin resistance. The purpose of this study is to identify gene polymorphisms that confer susceptibility to the metabolic syndrome and to make up a new health guidance program based on genetic risk assessment. About 25% of male employees over 45 years old in a certain company are diagnosed with the metabolic syndrome in medical examination. We, the researchers at Nagoya University, will analyze gene polymorphism and various biomarkers of over 3500 company employees.


Condition
Healthy
Metabolic Syndrome X
Hyperlipidemia
Hypertension
Diabetes Mellitus

Study Type: Observational
Study Design: Natural History, Longitudinal, Case Control, Retrospective/Prospective Study
Official Title: Assessment of Genetic Risk of Metabolic Syndrome in Company Employee and Making New Health Guidance Program (NGK Study)

Resource links provided by NLM:


Further study details as provided by Nagoya University:

Estimated Enrollment: 4000
Study Start Date: September 2006
  Eligibility

Ages Eligible for Study:   20 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy subjects who work for a certain company
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00408824

Contacts
Contact: Kenji Yasui, MD, PhD +81-52-788-6211 kenji@riem.nagoya-u.ac.jp

Locations
Japan, Aichi
Department of Bio-information Analysis, Research Institute of Environmental Medicine, Nagoya University Recruiting
Nagoya, Aichi, Japan, 464-8601
Contact: Kenji Yasui, MD, PhD     +81-52-788-6211     kenji@riem.nagoya-u.ac.jp    
Principal Investigator: Kenji Yasui, MD, PhD            
Sponsors and Collaborators
Nagoya University
Investigators
Study Chair: Kenji Yasui, MD, PhD Department of Bio-information Analysis, Research Institute of Environmental Medicine, Nagoya University
  More Information

No publications provided

Study ID Numbers: RIEM-G-3
Study First Received: December 6, 2006
Last Updated: September 19, 2007
ClinicalTrials.gov Identifier: NCT00408824     History of Changes
Health Authority: Japan: Ministry of Education, Culture, Sports, Science and Technology

Keywords provided by Nagoya University:
insulin resistance
adipocytokine
Metabolic syndrome
Diabetes

Study placed in the following topic categories:
Hyperlipidemias
Metabolic Syndrome X
Metabolic Diseases
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Healthy
Insulin
Abdominal Obesity Metabolic Syndrome
Hyperinsulinism
Endocrinopathy
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Disorder
Dyslipidemias
Hypertension
Lipid Metabolism Disorders

Additional relevant MeSH terms:
Hyperlipidemias
Metabolic Syndrome X
Metabolic Diseases
Disease
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Hyperinsulinism
Pathologic Processes
Syndrome
Cardiovascular Diseases
Insulin Resistance
Glucose Metabolism Disorders
Dyslipidemias
Hypertension
Lipid Metabolism Disorders

ClinicalTrials.gov processed this record on September 01, 2009